How likely is it that the Fda would ask for another study after the phase 3 we are currently in now? I recall NH mentioning on the conference call that if the Fda ask for more studies, we will do those for them.It sounded like that was a possibility.
I know in this case Ib was correct as there is not a chance the Eli drug will go to market in the first 3 months of 2016
Does that mean that we shareholders would basically become owners of Epic after they join?
Yes I know he said that too, like he said that he did not think the Fda would require a P3 study but it turns out he was wrong about that. Remember?
I listened to the last conference call and they did say the trials would start in March but I don't believe they started when we were tols they would start. All the name calling in the world will not change that fact.
Thank you, Elite and BK never crosses my mind as we now have 9? drugs on the market with more to come not to mention the Eli basket of explosive drugs. The waiting is hard and the lower portfolio value hurts but as long as we move forward we are good.
I am only asking a question and not trashing a stock that I am invested in. Are warrants also converted in order to sell shares in some cases?
Where are you gathering your information about these so called failed trials?